Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Migraines More Prevalent In Women
Headaches are a widespread problem in the United States, affecting roughly 45 million people. Migraine headaches affect millions of Americans each year they are the most common type of headache that sends patients running to their doctor"s office. Migraines occur when constricting blood vessels in the brain cause intense, recurring vascular headaches. Like other forms of headaches, women suffer from migraines more frequently than men.
generic viagra online
Why We Learn More From Our Successes Than Our Failures--MIT Study Sheds Light On The Brain's Ability To Change In Response To Learning
If you"ve ever felt doomed to repeat your mistakes, researchers at MIT"s Picower Institute for Learning and Memory may have explained why: brain cells may only learn from experience when we do something right and not when we fail.
News of the day
Melbourne Researchers Break Through On Schizophrenia
In a world first, Melbourne scientists have made a critical breakthrough in understanding the differences in the brains of people with schizophrenia.
Nutrition

Biomarkers In Cardiovascular Endocrinology: The Endocrine Society's 2009 Corporate Liaison Board Forum

The Endocrine Society"s Corporate Liaison Board (CLB) will host its annual forum on Wednesday June 10, as part of ENDO 09, the Society"s 91th Annual Meeting. The 2009 topic for the forum is "Biomarkers in Cardiovascular Endocrinology in Clinical Trials & Drug Development." The forum includes speakers from industry, academia, and government engaged in multi-perspective discussion on biomarkers in cardiovascular endocrinology, specifically as they relate to clinical trials and drug development. Issues to be discussed by forum participants include: - The Mandate for Development of Biomarkers of Atherosclerotic Cardiovascular Disease: Future Implications David A. Fryburg, MD-- Pfizer, Inc. - Novel Cardiovascular Biomarkers: Experience with Lp-PLA2 Joseph P. McConnell, PhD-- Mayo Clinic - Biomarkers in Cardiovascular Endocrinology in Clinical Trials and Drug Development: Regulatory Perspective Mary H. Parks, MD-- US Food and Drug Administration "This yearly forum provides an excellent opportunity for all perspectives to join together to discuss critical health issues-from the laboratory to drug development through the regulatory process," said Society Program Director, Sethu K. Reddy, MD, MBA. "We encourage a thoughtful interchange between panelists and forum attendees." The CLB serves as an opportunity for regular and direct communication between the Society, The Hormone Foundation, and the pharmaceutical and biotechnology industry in endocrinology. The 2009 forum will be held at the Renaissance Washington DC Hotel in the Grand Ballroom. The session begins at 6:30 p.m. (ET). Reporters may register by contacting Arlyn G. Riskind at (202) 431-9495; ariskind@endo-society.org. The Endocrine Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009